
Midatech Pharma plc MTP
Annual report 2024
added 03-21-2026
Midatech Pharma plc EBITDA per Share 2011-2026 | MTP
Annual EBITDA per Share Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -0.09 | -2.51 K | -1.23 K | -19 | -25.5 | -40.5 | -42.8 | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.09 | -2.51 K | -554 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Assembly Biosciences
ASMB
|
-1.07 | $ 28.46 | 3.45 % | $ 319 M | ||
|
Ascendis Pharma A/S
ASND
|
-8.25 | $ 221.88 | -0.87 % | $ 5 B | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Axsome Therapeutics
AXSM
|
-3.34 | $ 156.92 | -1.23 % | $ 7.81 B | ||
|
Galera Therapeutics
GRTX
|
-0.37 | - | -32.59 % | $ 7.61 M | ||
|
Pharming Group N.V.
PHAR
|
1.16 | $ 15.36 | -0.71 % | $ 7.59 B | ||
|
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.37 | -4.2 % | $ 350 M | ||
|
Kamada Ltd.
KMDA
|
-0.02 | $ 8.5 | -1.39 % | $ 260 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Benitec Biopharma
BNTC
|
-0.24 | $ 10.98 | -4.52 % | $ 452 M | ||
|
Inventiva S.A.
IVA
|
-1.33 | $ 5.78 | -4.3 % | $ 138 M | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Compugen Ltd.
CGEN
|
-0.41 | $ 2.09 | -0.95 % | $ 195 M | ||
|
Tiziana Life Sciences PLC
TLSA
|
-0.28 | $ 1.21 | -3.97 % | $ 71.5 M | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
PainReform Ltd.
PRFX
|
-7.2 | $ 2.28 | -0.44 % | $ 1.03 M | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
Foghorn Therapeutics
FHTX
|
-1.32 | $ 5.0 | 2.25 % | $ 315 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 3.4 | -3.68 % | $ 1.02 B | ||
|
BioMarin Pharmaceutical
BMRN
|
2.55 | $ 54.13 | -1.64 % | $ 10.4 B | ||
|
Curis
CRIS
|
-7.03 | $ 0.77 | 1.89 % | $ 4.86 M | ||
|
Bellerophon Therapeutics
BLPH
|
-2.34 | - | -74.18 % | $ 955 K | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
-1.54 | $ 1.52 | -5.59 % | $ 178 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 7.7 | -5.87 % | $ 1.29 B | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Cellectis S.A.
CLLS
|
-2.92 | $ 3.34 | -4.02 % | $ 116 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-0.46 | $ 4.24 | -2.97 % | $ 704 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | ||
|
Cardiff Oncology
CRDF
|
-0.73 | $ 1.8 | -1.1 % | $ 120 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Cabaletta Bio
CABA
|
-62.7 | $ 2.94 | -3.29 % | $ 3.43 M | ||
|
Iterum Therapeutics
ITRM
|
-0.95 | $ 0.16 | -5.45 % | $ 3.15 M | ||
|
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M |